Diana Peng Bockus

Form D signer

Diana Peng Bockus

Chief Executive Officer at NGM Bio

Form D signer

Capital raised by NGM Bio

$142.0M+$142.0M latest round

1 Form D filing · first filed Jul 2024 · South San Francisco, CA

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: 2024
30D INTEREST: —

Career

1 company on file · founded 2024

NGM BioBiotech · South San Francisco, CAsince 2024

Chief Executive Officer

Signatory on NGM Bio's Form D filings · $142.0M raised across 1

Company filings

via EDGAR · Form D for NGM Bio1

DateCompanyFormAmountRole on filing

Jul 5, 2024NGM BioForm D/A+$142.0MChief Executive Officer

Form D/AJul 5, 2024 · NGM Bio+$142.0Mas Chief Executive Officer

Overview

Last filing Jul 5, 2024

Diana Peng Bockus is on file as Chief Executive Officer at NGM Bio in South San Francisco, CA. NGM Bio has 1 Form D filing on record, $142.0M raised in total. Diana Peng Bockus appears as a signatory on the company's filings.

LinkedIn profile

Teammates

NGM Bio · 1

Tim KutzkeyDirector

Products

NGM Bio · 1

NGM120Clinical-stage biologic therapeutic

An investigational monoclonal antibody antagonist of GFRAL, the receptor for GDF15, designed to block GDF15 signaling in brainstem cells that trigger nausea, vomiting and appetite suppression.